Stelios Kympouropoulos
Lobbying Activity
Meeting with European Cancer Organisation
9 Apr 2024 · European cancer plan
Meeting with International Diabetes Federation European Region
3 Apr 2024 · discussion on diabetes
Meeting with Novartis International AG
20 Mar 2024 · rare diseases
Meeting with Gilead Sciences
19 Mar 2024 · prevention and raising awareness on combating HIV
Meeting with Terumo Blood and Cell Technologies
6 Mar 2024 · sickle cell disease
Meeting with Partners For Patients NGO
5 Mar 2024 · unused medicines
Meeting with Alexion Pharmaceuticals
22 Feb 2024 · rare diseases
Meeting with EUROPEAN ORGANISATION FOR RARE DISEASES
21 Feb 2024 · rare diseases
Meeting with Association of the European Self-Care Industry
15 Feb 2024 · discussion on the revision of Pharmaceutical Legislation
Meeting with European Confederation of Pharmaceutical Entrepreneurs
15 Feb 2024 · rare diseases
Meeting with
17 Jan 2024 · Kangaroo Lunch debate on Platform Technologies and the pharmaceutical legislation review
Meeting with Microsoft Corporation
16 Jan 2024 · AI and impact of technology on democracy, competitiveness, resilience and skills
Meeting with Novo Nordisk A/S
16 Nov 2023 · discussion on the General Pharmaceutical Package revision
Meeting with Eli Lilly and Company
8 Nov 2023 · discussion on the General Pharmaceutical Package revision
Meeting with MEDICINES FOR EUROPE
27 Oct 2023 · discussion on the General Pharmaceutical Package revision
Meeting with H. Lundbeck A/S
25 Oct 2023 · discussion on mental health
Meeting with Boehringer Ingelheim
24 Oct 2023 · discussion on the General Pharmaceutical Package revision
Meeting with ΑΣΤΙΚΗ ΜΗ ΚΕΡΔΟΣΚΟΠΙΚΗ ΕΤΑΙΡΕΙΑ ΚΑΡΚΙΝΑΚΙ ΕΝΗΜΕΡΩΣΗ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ ΣΤΗΝ ΠΑΙΔΙΚΗ ΚΑΙ ΕΦΗΒΙΚΗ ΗΛΙΚΙΑ
20 Oct 2023 · health policies
Meeting with Avicenna Alliance
18 Oct 2023 · discussion on the General Pharmaceutical Package revision
Meeting with Affordable Medicines Europe
9 Oct 2023 · discussion on the General Pharmaceutical Package revision
Meeting with Partners For Patients NGO
7 Oct 2023 · discussion on the diversity on clinical trials and patients involvement in research
Meeting with SMEunited aisbl
18 Apr 2023 · Meeting on Strengthening Social Dialogue
Meeting with EUROPEAN TRADE UNION CONFEDERATION
11 Apr 2023 · Trade Union Intergroup meeting
Meeting with Bristol-Myers Squibb Company
7 Apr 2023 · National Action Plan for Cancer and EU opportunities
Meeting with Tetra Pak Group
4 Apr 2023 · EU Packaging and Packaging Waste Regulation
Meeting with MEDICINES FOR EUROPE
20 Mar 2023 · Upcoming pharmaceutical legislation
Meeting with Metrc LLC
28 Feb 2023 · Digital tools, patient safety and medical cannabis Regulation
Meeting with Johnson Johnson
27 Feb 2023 · general discussion on the Pharmaceutical Strategy revision
Meeting with CSL Behring
12 Jan 2023 · discussion on SoHO regulation
Meeting with Platform for Better Oral Health in Europe
19 Dec 2022 · Oral health
Meeting with Novavax
9 Nov 2022 · Lessons-learnt from COVID-19
Meeting with Moderna, Inc.
11 Oct 2022 · Lessons-learnt from COVID-19
Meeting with Environmental Investigation Agency
7 Sept 2022 · the revision of fluorinated gases regulation
Meeting with Eurelectric aisbl
5 Sept 2022 · phase out of f-gases and switchgears
Meeting with
19 Jul 2022 · pMDIs, phase out of f-gases
Meeting with The Chemours Company
13 Jul 2022 · the revision of fluorinated gases regulation
Meeting with AstraZeneca PLC
12 Jul 2022 · pMDIs
Meeting with American Chamber of Commerce to the European Union
6 Jul 2022 · phase out of f gases
Meeting with EUROPEAN NETWORK ON INDEPENDENT LIVING BRUSSELS
1 Apr 2022 · European Care Strategy
Meeting with AGE Platform Europe
30 Mar 2022 · European Care Strategy
Meeting with Eurocarers
2 Mar 2022 · European Care Strategy